Cargando…
CD24+CD44+CD54+EpCAM+ gastric cancer stem cells predict tumor progression and metastasis: clinical and experimental evidence
BACKGROUND: Gastric cancer (GC) is a leading cause of cancer-related deaths worldwide. Specific and thorough identification of cancer cell subsets with higher tumorigenicity and chemoresistance, such as cancer stem cells (CSCs), could lead to the development of new and promising therapeutic targets....
Autores principales: | Gómez-Gallegos, Angel A., Ramírez-Vidal, Lizbeth, Becerril-Rico, Jared, Pérez-Islas, Elizabeth, Hernandez-Peralta, Zuly J., Toledo-Guzmán, Mariel E., García-Carrancá, Alejandro, Langley, Elizabeth, Hernández-Guerrero, Angélica, López-Casillas, Fernando, Herrera-Goepfert, Roberto, Oñate-Ocaña, Luis F., Ortiz-Sánchez, Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898964/ https://www.ncbi.nlm.nih.gov/pubmed/36737794 http://dx.doi.org/10.1186/s13287-023-03241-7 |
Ejemplares similares
-
Targeting EpCAM (CD326) for immunotherapy in hepatoblastoma
por: Armeanu-Ebinger, Sorin, et al.
Publicado: (2013) -
EpCAM (CD326) finding its role in cancer
por: Baeuerle, P A, et al.
Publicado: (2007) -
EpCAM (CD326) finding its role in cancer
por: Baeuerle, P A, et al.
Publicado: (2007) -
The detection of EpCAM(+) and EpCAM(–) circulating tumor cells
por: Wit, Sanne de, et al.
Publicado: (2015) -
EpCAM (CD326) is differentially expressed in craniopharyngioma subtypes and Rathke’s cleft cysts
por: Thimsen, Vivian, et al.
Publicado: (2016)